These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31922536)

  • 1. Discontinuing Contact Precautions for Vancomycin-Resistant Enterococcus (VRE) Is Associated With Rising VRE Bloodstream Infection Rates in Ontario Hospitals, 2009-2018: A Quasi-experimental Study.
    Johnstone J; Shing E; Saedi A; Adomako K; Li Y; Brown KA; Garber G
    Clin Infect Dis; 2020 Oct; 71(7):1756-1759. PubMed ID: 31922536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discontinuing MRSA and VRE contact precautions: Defining hospital characteristics and infection prevention practices predicting safe de-escalation.
    Martin EM; Colaianne B; Bridge C; Bilderback A; Tanner C; Wagester S; Yassin M; Pontzer R; Snyder GM
    Infect Control Hosp Epidemiol; 2022 Nov; 43(11):1595-1602. PubMed ID: 34847970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the relationship between vancomycin-resistant Enterococcus control practices and the incidence of health care-associated Clostridioides difficile infections in Ontario.
    Ling R; Achonu C; Li Y; Katz KC; Garber G; Johnstone J
    Am J Infect Control; 2020 Mar; 48(3):324-326. PubMed ID: 31551123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Discontinuing Contact Precautions for Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus: An Interrupted Time Series Analysis.
    Bearman G; Abbas S; Masroor N; Sanogo K; Vanhoozer G; Cooper K; Doll M; Stevens MP; Edmond MB
    Infect Control Hosp Epidemiol; 2018 Jun; 39(6):676-682. PubMed ID: 29580304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of Routine Contact Precautions for Endemic Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus: A Retrospective Quasi-Experimental Study.
    Martin EM; Russell D; Rubin Z; Humphries R; Grogan TR; Elashoff D; Uslan DZ
    Infect Control Hosp Epidemiol; 2016 Nov; 37(11):1323-1330. PubMed ID: 27457254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of discontinuing contact precautions and enforcement of basic hygiene measures on nosocomial vancomycin-resistant Enterococcus faecium transmission.
    Eichel VM; Boutin S; Frank U; Weigand MA; Heininger A; Mutters NT; Büchler MW; Heeg K; Nurjadi D
    J Hosp Infect; 2022 Mar; 121():120-127. PubMed ID: 34861314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of vancomycin-resistant enterococci (VRE)-associated morbidity following relaxation of VRE screening and isolation precautions in a tertiary care hospital.
    Popiel KY; Miller MA
    Infect Control Hosp Epidemiol; 2014 Jul; 35(7):818-25. PubMed ID: 24915209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can we reduce contact precautions days for methicillin-resistant Staphylococcus aureus and vancomycin resistant Enterococcus infected patients?
    Thottacherry ED; Hassoun A
    J Infect Public Health; 2020 Aug; 13(8):1118-1122. PubMed ID: 32336607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proactive infection control measures to prevent nosocomial transmission of vancomycin-resistant enterococci in Hong Kong.
    Cheng VC; Tai JW; Chen JH; So SY; Ng WC; Hung IF; Leung SS; Wong SC; Chan TC; Chan FH; Ho PL; Yuen KY
    J Formos Med Assoc; 2014 Oct; 113(10):734-41. PubMed ID: 24796821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin-Resistant Enterococci: Epidemiology, Infection Prevention, and Control.
    Reyes K; Bardossy AC; Zervos M
    Infect Dis Clin North Am; 2016 Dec; 30(4):953-965. PubMed ID: 27660091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations for the successful control of a large outbreak of vancomycin-resistant Enterococcus faecium in a non-endemic hospital setting.
    Frakking FNJ; Bril WS; Sinnige JC; Klooster JEV; de Jong BAW; van Hannen EJ; Tersmette M
    J Hosp Infect; 2018 Dec; 100(4):e216-e225. PubMed ID: 29475013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of a hospital-wide vancomycin-resistant Enterococcus faecium outbreak in a Dutch general hospital, 2014-2017: successful control using a restrictive screening strategy.
    Weterings V; van Oosten A; Nieuwkoop E; Nelson J; Voss A; Wintermans B; van Lieshout J; Kluytmans J; Veenemans J
    Antimicrob Resist Infect Control; 2021 Feb; 10(1):38. PubMed ID: 33602300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of discontinuing single-room isolation of patients with vancomycin-resistant enterococci: a quasi-experimental single-centre study in South Korea.
    Park S; Bae S; Kim EO; Chang E; Kim MJ; Chong YP; Choi SH; Lee SO; Kim YS; Jung J; Kim SH
    J Hosp Infect; 2024 May; 147():77-82. PubMed ID: 38492645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of transmission of vancomycin-resistant Enterococcus faecium in a long-term-care facility.
    Armstrong-Evans M; Litt M; McArthur MA; Willey B; Cann D; Liska S; Nusinowitz S; Gould R; Blacklock A; Low DE; McGeer A
    Infect Control Hosp Epidemiol; 1999 May; 20(5):312-7. PubMed ID: 10349946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Horizontal infection prevention measures and a risk-managed approach to vancomycin-resistant enterococci: An evaluation.
    Bryce E; Grant J; Scharf S; Dempster L; Lau TT; Laing F; Shajari S; Forrester L
    Am J Infect Control; 2015 Nov; 43(11):1238-43. PubMed ID: 26190379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An outbreak of vancomycin-resistant enterococci in a hematology-oncology unit: control by patient cohorting and terminal cleaning of the environment.
    Sample ML; Gravel D; Oxley C; Toye B; Garber G; Ramotar K
    Infect Control Hosp Epidemiol; 2002 Aug; 23(8):468-70. PubMed ID: 12186215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconsidering contact precautions for endemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.
    Morgan DJ; Murthy R; Munoz-Price LS; Barnden M; Camins BC; Johnston BL; Rubin Z; Sullivan KV; Shane AL; Dellinger EP; Rupp ME; Bearman G
    Infect Control Hosp Epidemiol; 2015 Oct; 36(10):1163-72. PubMed ID: 26138329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stopping the routine use of contact precautions for management of MRSA and VRE at three academic medical centers: An interrupted time series analysis.
    Haessler S; Martin EM; Scales ME; Kang L; Doll M; Stevens MP; Uslan DZ; Pryor R; Edmond MB; Godbout E; Abbas S; Bearman G
    Am J Infect Control; 2020 Dec; 48(12):1466-1473. PubMed ID: 32634537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninfectious Hospital Adverse Events Decline After Elimination of Contact Precautions for MRSA and VRE.
    Martin EM; Bryant B; Grogan TR; Rubin ZA; Russell DL; Elashoff D; Uslan DZ
    Infect Control Hosp Epidemiol; 2018 Jul; 39(7):788-796. PubMed ID: 29745356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The discontinuation of contact precautions for methicillin-resistant
    Schrank GM; Snyder GM; Davis RB; Branch-Elliman W; Wright SB
    BMJ Qual Saf; 2020 Oct; 29(10):1-2. PubMed ID: 31320496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.